Recurrence of type I membranoproliferative glomerulonephritis after renal transplantation: Analysis of the incidence, risk factors, and impact on graft survival

Transplantation

Volumn 63, Issue 11, 1997, Pages 1628-1633

  Andresdottir, Margret B ^a   Assmann, Karel J M ^a   Hoitsma, Andries J ^a   Koene, Robert A P ^a   Wetzels, Jack F M ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

HLA B8 ANTIGEN; HLA DR3 ANTIGEN;

ADULT; ARTICLE; CADAVER KIDNEY; CLINICAL ARTICLE; GRAFT FAILURE; GRAFT SURVIVAL; HAPLOTYPE; HLA SYSTEM; HUMAN; KIDNEY TRANSPLANTATION; MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS; PRIORITY JOURNAL; PROTEINURIA; RECURRENT DISEASE;

ADULT; CADAVER; FEMALE; GLOMERULONEPHRITIS, MEMBRANOPROLIFERATIVE; GRAFT SURVIVAL; HUMANS; INCIDENCE; KIDNEY TRANSPLANTATION; MALE; RECURRENCE; REOPERATION; TISSUE DONORS;

EID: 0030941827     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199706150-00016     Document Type: Article

References (28)

1. Glassock RJ, Cohen AH, Adler SG. Primary glomerular diseases. In: Brenner BM, ed. The Kidney. Philadelphia: Saunders, 1996: 1392.
2. Cameron JS, Turner DR, Heaton J, et al. Idiopathic mesangiocapillary glomerulonephritis: comparison of types I and II in children and adults and long-term prognosis. Am J Med 1983; 74: 175.
3. O'Meara Y, Green A, Carmody M, et al. Recurrent glomerulonephritis in renal transplants: fourteen years' experience. Nephrol Dial Transplant 1989; 4: 730.
4. Hoitsma AJ, Lier van HJJ, Wetzels JFM, Berden JHM, Koene RAP. Cyclosporin treatment with conversion after three months versus conventional immunosuppression in renal allograft recipients. Lancet 1987; 14: 584.
5. Hilbrands LB, Hoitsma AJ, Koene RAP. Randomized, prospective trial of cyclosporine monotherapy versus azathioprine-prednisone from three months after renal transplantation. Transplantation 1996; 61: 1038.
6. Cameron JS, Turner DR. Recurrent glomerulonephritis in allografted kidneys. Clin Nephrol 1977; 7: 47.
7. Vangelista A, Frasca GM, Martella D, Bonomini V. Glomerulonephritis in renal transplantation. Nephrol Dial Transplant 1990; 5(suppl 1): 42.
8. Welch TR, Beischel L, Balakrishnan K, Quinlan M, West CD. Major-histocompatibility-complex extended haplotypes in membranoproliferative glomerulonephritis. N Engl J Med 1986; 314: 1476.
9. Tomlanovich S, Vincenti F, Amend W, et al. Is cyclosporine effective in preventing recurrence of immune-mediated glomerular disease after renal transplantation? Transplant Proc 1988; 20: 285.
10. Schwarz A, Krause P, Offerman G, Keller F. Recurrent and de novo renal disease after kidney transplantation with or without cyclosporine A. Am J Kidney Dis 1991; 17: 524.
11. Freedman BI, Graves JW, Burkart JM, et al. The impact of different immunosuppressant regimens on recurrent glomerulonephritis. Transplant Proc 1989; 21: 2121.
12. Michielsen P. Recurrence of the original disease: does this influence renal graft failure? Kidney Int 1995; 48 (suppl 52): S79.
13. Berthoux FC, Ducret F, Colon S, Blanc-Brunat N, Zech PY, Traeger J. Renal transplantation in mesangioproliferative glomerulonephritis (MPGN): relationship between the high frequency of recurrent glomerulonephritis and hypocomplementemia. Kidney Int Suppl 1975; 7: S323.
14. McLean RH, Geiger H, Burke B, et al. Recurrence of membranoproliferative glomerulonephritis following kidney transplantation. Am J Med 1976; 60: 60.
15. Cameron JS. Glomerulonephritis in renal transplants. Transplantation 1982; 34: 237.
16. Ramos EL. Recurrent diseases in the renal allograft. J Am Soc Nephrol 1991; 2: 109.
17. Davison AM. Renal transplantation: recurrence of original disease with particular reference to primary glomerulonephritis. Nephrol Dial Transplant 1995; 10 (suppl 1): 81.
18. Morzycka M, Croker BP, Seigler HF, Tisher CC. Evaluation of recurrent glomerulonephritis in kidney allografts. Am J Med 1982; 72: 588.
19. Noël LH, Descamps B, Jungers P, et al. HLA antigen in three types of glomerulonephritis. Clin Immunol Immunopathol 1978; 10: 19.
20. Berger J, Noël LH, Nabarra B. Recurrence of mesangial IgA nephropathy after renal transplantation. Contrib Nephrol 1984; 40: 195.
21. Bachman U, Biava C, Amend W, et al. The clinical course of IgA-nephropathy and Henoch-Schönlein purpura following renal transplantation. Transplantation 1986; 42: 511.
22. Glicklich D, Matas AJ, Sablay LB, et al. Recurrent membranoproliferative glomerulonephritis type I in successive renal transplants. Am J Nephrol 1987; 7: 143.
23. Zimmerman SW, Hyman LR, Uehling DT, Burkholder PM. Recurrent membranoproliferative glomerulonephritis with glomerular properdin deposition in allografts. Ann Intern Med 1974; 80: 169.
24. Hamburger J, Berger J, Hinglais N, Descamps B. New insights into the pathogenesis of glomerulonephritis afforded by the study of renal allografts. Clin Nephrol 1973; 1: 3.
25. Moritz MJ, Burke JF, Jarrell BE, Carabasi RA. The incidence of membranoproliferative glomerulonephritis in renal allografts. Transplant Proc 1987; 19: 2206.
26. Mathew TH, Mathews DC, Hobbs JB, Kincaid-Smith P. Glomerular lesions after renal transplantation. Am J Med 1975; 59: 177.
27. Hamburger J, Crosnier J, Noël LH. Recurrent glomerulonephritis after renal transplantation. Annu Rev Med 1978; 29: 67.
28. Curtis JJ, Wyatt RJ, Bhathena D, Lucas BA, Holland NH, Luke RG. Renal transplantation for patients with type I and type II membranoproliferative glomerulonephritis. Am J Med 1979; 66: 216.